Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
70.44
+1.03 (1.48%)
Dec 20, 2024, 4:00 PM EST - Market closed
Insmed Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Insmed stock have an average target of 84.29, with a low estimate of 42 and a high estimate of 105. The average target predicts an increase of 19.66% from the current stock price of 70.44.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 22, 2024.
Analyst Ratings
The average analyst rating for Insmed stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
Buy | 7 | 7 | 7 | 7 | 7 | 7 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $74 → $83 | Buy | Maintains | $74 → $83 | +17.83% | Nov 22, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $100 → $105 | Strong Buy | Reiterates | $100 → $105 | +49.06% | Nov 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +27.77% | Nov 1, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +41.96% | Oct 11, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $84 → $86 | Strong Buy | Maintains | $84 → $86 | +22.09% | Oct 9, 2024 |
Financial Forecast
Revenue This Year
363.80M
from 305.21M
Increased by 19.20%
Revenue Next Year
514.51M
from 363.80M
Increased by 41.43%
EPS This Year
-5.52
from -5.34
EPS Next Year
-4.41
from -5.52
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 384.3M | 679.7M | 1.5B | |||
Avg | 363.8M | 514.5M | 1.1B | |||
Low | 344.0M | 396.9M | 616.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 25.9% | 86.8% | 194.5% | |||
Avg | 19.2% | 41.4% | 107.0% | |||
Low | 12.7% | 9.1% | 19.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -5.41 | -3.28 | -0.76 | |||
Avg | -5.52 | -4.41 | -2.48 | |||
Low | -5.57 | -5.31 | -4.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.